Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Preleukemia × filanesib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 2 Preleukemia 1 Plasmacytoma 1 Paraproteinemias 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1

Interventions

ruxolitinib 1 filanesib 1 Stem Cell Transplantation 1 Melphalan 1 Clofarabine 1 CPI-0610 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637052 2021-02-08

A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia

Pfizer

Phase 1/2 Completed

Other hematologic neoplasm

Preleukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡